Unparalleled in its scope and depth, this book brings together proteomic approaches use in the discovery and development of diagnostic and prognostic biomarkers that are applicable to all clinical fields.

Following an overview of state-of-the-art technologies and strategies currently being applied to clinical proteomics, the book focuses on individual diseases including cancer, diabetes, stroke and cardiopulmonary, renal and autoimmune diseases as well as clinical toxicology finishing with a discussion of the future of clinical proteomics. This new discipline in molecular medicine holds promise to revolutionize the practice of medicine and this book is a first.